Home Abcam

Abcam

acquired
IPO Delisting
Developer of Life Science Reagents and Tools

Basic Information

As an innovator in life science reagents and tools, Abcam, Inc. aims to serve life science researchers worldwide to help them achieve their missions more quickly. Two-thirds of the 750,000 life science researchers globally use Abcam's affinity binders, reagents, biomarkers, and assays.
Abcam, Inc.
Cambridge,England,United Kingdom
more than 500 people
January 01, 1998
--